Literatur
- 1
Finzen A.
Wir dankbaren Ärzte.
Dtsch Ärztebl.
2002;
99
A 766-769
- 2 Shaw G B. Des Doktors Dilemma. Frankfurt; Suhrkamp 1991
- 3 Angell M. The Truth about the Drug Companies. NY; Random House 2004
- 4
Lexchin J, Bero L A, Djulbegovic B, Clark O.
Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
BMJ.
2003;
326 (7400)
1167-1170
- 5
Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S.
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats
olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation
antipsychotics.
Am J Psychiatry.
2006;
163 (2)
185-194
- 6
Chan A W, Hrobjartsson A, Haahr M T, Gotzsche P C, Altman D G.
Empirical evidence for selective reporting of outcomes in randomized trials: comparison
of protocols to published articles.
JAMA.
2004;
291 (20)
2457-2465
- 7
Brennan T A, Rothman D J, Blank L, Blumenthal D, Chimonas S C, Cohen J J, Goldman J,
Kassirer J P, Kimball H, Naughton J, Smelser N.
Health industry practices that create conflicts of interest: a policy proposal for
academic medical centers.
JAMA.
2006;
295 (4)
429-433
- 8
Fenning T M.
Fraud offers big rewards for relatively little risk.
Nature.
2004;
427 (6973)
393
- 9 Office of Research Integrity, Office of Public Health and Science, Department of
Health and Human Services .Scientific Misconduct Investigations 1993 - 1997, 1998. http://ori.dhhs.gov/documents/misconduct_investigations_1993_1997.pdf
- 10 Verein „Freiwillige Selbstkontrolle für die Arzneimittelindustrie e. V.” .FS Arzneimittelindustrie-Kodex. http://www.vfa.de/de/vfa/fs-arzneimittelindustrie/fsam-dokumente/fsa-kodex.html
- 11
Moher D, Cook D J, Eastwood S, Olkin I, Rennie D, Stroup D F.
Improving the quality of reports of meta-analyses of randomised controlled trials:
the QUOROM statement. Quality of Reporting of Meta-analyses.
Lancet.
1999;
354 (9193)
1896-1900
- 12
Moher D, Schulz K F, Altman D. CONSORT Group .
The CONSORT Statement: revised recommendations for improving the quality of reports
of parallel-group randomized trials 2001.
Explore (NY).
2005;
1 (1)
40-45
Prof. Dr. Asmus Finzen
Spalenvorstadt 3
4051 Basel, Schweiz
eMail: asmus.finzen@vtxmail.ch
Prof. Dr. med. Jürgen Fritze
Verband der privaten Krankenversicherung e. V.
Bayenthalgürtel 26
50968 Köln
eMail: juergen.fritze@dgn.de
